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SlLlmmal'y 
Immunoglobulins drive efficient antigen capture by antigen presenting calls for processing and 
presentation on class II MHC-molecules. High affinity antibody/antigen interactions are stable 
at endosomal/lysosomal pH thus altering  the substrate for antigen processing.  We show that 
this can result in strong  suppression of presentation  of some T  cell epitopes.  This effect was 
observed when the antibody specificity was a B call surface Ig, or formed part of an immune 
complex. In the latter case the presence of the suppressing antibody boosts presentation of other 
T  cell epitopes through enhanced uptake into Fc receptor bearing cells. The influence of bound 
antibodies on the outcome of antigen processing may influence with T  cell epitopes dominate 
T  cell responses and may change  the focus of the response with  time. 
T 
he possibility that  antibody binding to antigen might 
influence processing and consequently, presentation of 
T  cell epitopes on dass II MHC has often been debated. Pi- 
oneering studies by Berzofsky and Cdada and their coUeagues 
(1-4) indicated that  antibody binding  could "differentially 
enhance" presentation to some T  cell clones either through 
effects on antigen  uptake or on proteolytic processing.  To 
address these questions it is essential to use a system that would 
allow the effects of antibody on uptake and processing to 
be clearly dissected and where we could analyze the effect 
of a single antibody specificity both as an antigen receptor 
on B lymphocytes and as part  of an immune  complex. 
Earlier biochemical studies using tetanus toxin (tt)-specific 
human B lymphocyte clones (5)  showed that  high affinity 
antibody (Ig) binding to antigen influenced the course of an- 
tigen processing, measured by the appearance of intracellular 
radiolabded antigen fragments (6). Distinct fragments were 
generated in B cell clones with different epitope specificity 
and could be modified further in the presence of additional 
anti-tt Fabs (6). These and other studies where antigen/anti- 
body complexes were digested in vitro (7, 8) provided a pos- 
sible biochemical basis for the idea that the spectrum of pep- 
tides generated and subsequently displayed on class II MHC 
molecules might be influenced by the fine specificity of the 
antibodies used for antigen  capture  (1,  2). 
Here we demonstrate that antibody binding to tt can sup- 
press the generation of a T  cell epitope by a direct effect on 
processing, while at the same time enhance presentation of 
other  epitopes via an effect on uptake. 
Materials  and Methods 
Media and Reagents.  The medium used throughout was RPMI 
1640 supplemented with 2 mM L-glutamine, 1% nonessential amino 
acids, 1% pyruvate, 50/~g/m.1 kanamycin, 5  x  10  -s M 2-mercap- 
toethanol, and 10% FCS. Anti-tt antibodies (all IgG) were purified 
by chromatography on protein A Sepharose from concentrated cul- 
ture supernatants  of EBV-B cell clones, tt was a generous gift of 
N. Fairweather (Wellcome Biotech,  Kent,  UK). 
B and T Cell Clones.  Three tt specific EBV-B cell clones, iso- 
lated and maintained as previously described (5), were used as APC. 
They recognize nonoverlapping conformational epitopes which have 
not been precisely mapped.  The B cell done 4.2 recognizes the 
so-called B fragment of tt obtained by papain cleavage (1-864) and 
11.3 and 8.5 recognize the C fragment (865-1315). Two additional 
EBV-B cell clones specific for the B fragment (A46 and 12.1) were 
used as a source of antibody. From the same donor from which 
B cell clones 4.2, 8.5, and 11.3 were isolated in 1983, a new panel 
of 50 T cell clones was isolated and tested for their capacity to 
recognize tt presented by each of the three B cell clones. 
T Cell Proliferation.  2  x  104 T ceils were cultured with 2  x 
l& irradiated autologous EBV-B cells (6000 R) or 105 autologous 
PBMC (3000 R) in the presence of different concentrations  of tt 
in 200/xl RPMI-10% FCS in flat-bottomed microplates. After 48 h 
the cultures  were pulsed  with  1 /~Ci [3H]thymidine (sp act  5 
Ci/mM; Amersham Corp., Arlington  Heights,  IL) and the radio- 
activity incorporated was measured after 16 h by liquid scintilla- 
tion counting.  In some experiments tt and anti-tt antibodies were 
allowed to react in the wells of a flat-bottom  microtiter  plate for 
1 h before the addition  of APC and T cells. 
T CelIEpitope Mapping.  16-mers  overlapping by 6 residues and 
spanning the whole sequence of tt C-fragment  (865-1315) were 
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Results and Discussion 
Identification of B Cell/T Cell Incompatibilities.  To iden- 
tify T cell epitopes whose presentation might be influenced 
by bound antibodies, we first compared the ability of three 
tt-specific EBV-B cell clones, each recognizing a different epi- 
tope, to present tt to a panel of tt-spedfic T  cell clones. T 
cell clones KB18 and KB3 are typical of the majority of clones 
studied which showed no obvious B cell preference (Fig.  1, 
a and b). However, T cell clones KB37 and KB43 showed 
a strikingly different result, since they were only stimulated 
by B cell clone 4.2 and not by 11.3 and 8.5  (Fig.  1 c and 
d). Note that of the clones which showed no B cell prefer- 
ence, a range of sensitivity to antigen was observed, some 
with higher apparent affinity compared to KB43 and KB37, 
but also some with equal or lower affinity (see also Fig.  2). 
Using overlapping peptides based on the known sequence 
of tt (9, 10) the epitope recognized by these clones was mapped 
to residues 1174-1189. Epitope 1174-1189 is found in the so- 
called "C fragment" domain oftt (residues 865-1315)  which 
also includes the conformational epitopes recognized by the 
nonpermissive B cell clones 8.5 and 11.3. However, several 
other C fragment epitopes falIing on both sides of the sup- 
pressed epitope are efffciently presented by these B ceils; for 
example 947-967 (recognized by KB18) and 1273-1284  pre- 
viously defined (11). Thus, in spite of the very efficient an- 
tigen uptake and presentation to most T  cell clones, B cell 
clones 11.3 and 8.5 fail to generate the epitope  1174-1189 
to a level sufficient to drive T cell proliferation. At antigen 
concentrations which greatly exceed that needed to saturate 
membrane Ig (30 ltg/ml), all 3 B cell clones now presented 
epitope 1174-1189  equally well (data not shown) showing 
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Figure 1.  Differential  presentation  of the 1174-89 epitope  by different 
tt-specific B cell clones. Each panel represents  the proliferative  response 
ofa T cell clone to tt presented  by three tt-specific  EBV-B cells: 4.2 (El) 
11.3 (0) and 8.5 (O). (a) T cell clone  KB3; (b) T cell  done KB18, specific 
for (tt 947-967), (c) and (d) T cell clones KB37 and KB43 specific  for 
tt 1174-1189. 
that it is only the antigen taken up on membrane Ig which 
fails to generate this epitope. 
These results indicate that B cell/T cell incompatibilities 
can be found in an autologous panel of human lymphocyte 
clones. 
Suppressive  Effect of Sohble Antibody on Antigen Presentation 
by Permissive B Cells.  To confirm that B cell Ig specificity 
rather than clonal differences in antigen processing (12) ac- 
counted for the preferential B ceU/T cell pairing we tested 
the effect of adding soluble 11.3 or 8.5 antibody to the com- 
patible B cell/T cell combination 4.2/KB43,  thus creating 
a situation analogous to our earlier biochemical experiments 
(6), where additional antibody specificities are taken up, bound 
to antigen, in "piggyback" fashion. As shown in Fig. 2, a 
and b, addition of these antibodies caused a dose dependent 
inhibition of presentation by clone 4.2 B cells to KB43 T 
cells. This suppression was very effective; such that a molar 
equivalent of Ig to antigen was suffcient to strongly inhibit 
presentation of the 1174-1189 epitope (Fig. 2). Presentation 
to other T cell clones was not affected even at high concen- 
trations of these antibodies (5 #g/m1), ruling out the possi- 
bility that they were toxic or inhibited antigen uptake (Fig. 
2, c and d).  Thus these B cell/T cell incompatibilities can 
be directly attributed to antibody specificity and, importantly, 
the same specificity offered as soluble antibody can block the 
ability of an otherwise competent B cell to present antigen 
to a specific T  cell clone. 
Suppressive Effect of Antibody on Antigen Processing by FcR+ 
APC.  The suppressive effects of an antibody on processing 
might have a more widespread effect on the T cell response 
if the antibody can exert the same effect when present as part 
of an immune complex target to the Fc receptor bearing APC. 
Indeed, recent evidence indicates that priming and expan- 
sion of T  cells requires professional APC such as dendritic 
cells or macrophages, which are more abundant than antigen- 
specific B cells and can deliver costimulatory signals (13-16). 
However, the effect of antibodies on the processing of im- 
mune complexes is complicated by the fact that they also drive 
antigen uptake. 
Using autologous PBMC as a source of antigen presenting 
ceils and the same T  cell clones tested above,  we analyzed 
the effect on tt presentation of adding anti-tt monoclonal 
antibodies, either singly or in various combinations. Presen- 
tation of tt to the T  ceU clone KB18 (tt 947-967) was en- 
hanced by all antibodies tested singly and was boosted fur- 
ther by combining several specificities (Fig. 3 a) presumably 
due to enhanced Fc receptor-mediated antigen uptake in the 
presence of multiple antibodies (17). However, T  cell clone 
KB43 showed a strikingly different response to added anti- 
bodies (Fig.  3 b). Some antibodies, including the "compat- 
ible" antibody 4.2, enhanced presentation, and when com- 
bined with other anti-B fragment specificities  (4.2  +  12.1 
+  A46) presentation to KB43 was boosted still further. How- 
ever, when the "incompatible" antibody 11.3 was added as 
a fourth specificity to the cocktail of enhancing antibodies, 
presentation to KB43 was virtually abolished. Only at high 
doses of tt, where the antibody was insufficient to complex 
all the antigen, could presentation to KB43 be achieved. 
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Figure  2.  Soluble  11.3 and 8.5  anti- 
bodies selectively suppress  presentation of 
the 1174--1189  epitope by B cell done 4.2. 
(a) Proliferative response of clone KB43 
(1174-1189-specific) to tt presented by B 
cell clone 4.2 in the absence ([2]) or in 
the presence of antibody 11.3 at 5/~g/ml 
(11),  1/~g/ml (O) and 0.2/~g/ml (0). 
(b) Same cultures in the presence of 8.5 
antibody. (c and d) Proliferative response 
of clones KB25 (tt 1124-1139) and KB47 
(unmapped epitope between tt 1-865) in 
the absence (V]) or in the presence of 5 
/~g/ml 8.5 (0)  or 11.3 (11) antibody. 
Thus different  T  cell clones dearly illustrate  the distinct 
effects of antibody on presentation  in FcR + cells.  Antibody 
effects on uptake are invariably positive, as previously reported 
by others (17, 18), and as shown here, lead to enhanced pre- 
sentation of those epitopes whose processing is not affected 
by antibody binding. However, for other epitopes in this system 
(e.g.,  1174-1189)  the suppressive effect  of antibody 11.3 on 
processing dominates in spite  of enhanced antigen uptake, 
demonstrating that a single Ig-specificity  can block presen- 
tation of one T cell epitope while at the same time boosting 
the presentation of other T  cell epitopes by enhancing an- 
tigen capture  by Fc receptor  bearing cells. 
soluble molecules in immune complexes, we have found a 
dear instance where antibody can suppress T ceU epitope pre- 
sentation due to effects  on processing (Fig.  4). 
In considering the possible implications of these results, 
it is interesting to note that  the B cell producing the sup- 
pressing  antibody can still receive "help" through presenta- 
tion of other T  cell epitopes  which exist in a large antigen 
or protein complex (19),  thus sustaining production of the 
suppressing  antibody.  In contrast,  suppression  of the T cell 
Concluding Remarks 
Using an experimental  system where the same antibodies 
can be analyzed both as receptors on B lymphocytes and as 
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Figure  3.  Different T cell epitopes are enhanced or suppressed by 11.3 
antibody present  in immune complexes  taken  up by peripheral  blood 
mononuclear cells (PBMC). (a) T call done KB18 (947-967-specific) and 
(b) clone KB43 (1174-1189-specific)  were stimulated with increasing doses 
of tt in the presence of irradiated (3000 K) autologous PBMC in the ab- 
sence (N) or in the presence of the following antibodies:  11.3 (0),  4.2 
(Ia), 4.2  +  A46  +  12.1 (O), 4.2  +  A46  +  12.1 +  11.3 (A), each at 
1 /~g/m]. 
Figure  4.  Differential effect of antibody  on processing and presenta- 
tion of two tt C-fragment T  cell epitopes. 
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antibody acting on other B cells and on FcK + cells. Thus 
the suppressing effect of soluble antibody imposes an asym- 
metric or vectorial effect on T versus B cell responses to large 
antigens. However, for small antigens or peptide vaccines with 
few T cell epitopes a suppressive effect of antibody may even- 
tually feed back to shut down both the T  and then the B 
cell response. 
How are the 11.3 and 8.5 antibodies able to exert such 
a strong suppressive  effect on presentation of a T  cell epi- 
tope? The epitopes recognized by these antibodies are thus 
far only mapped to nonoverlapping conformational deter- 
minants in the tt C fragment (residues 865-1315), whereas 
the permissive antibody  (4.2)  recognizes the B  fragment 
(residues 1-864; references 5 and 6). Since it is known that 
quite large fragments of antigen  (>10  kD)  are protected 
during processing by the 11.3 and 8.5 antibodies (reference 
6 and P. D. Simitsek, unpublished), we suggest that these 
antibodies interfere with presentation by stabilizing relatively 
large domains, including the 1174-1189 epitope, which are 
not processed efllciently. Since the influence of Ig on antigen 
processing will eventually be overcome by further proteo- 
lytic processing, this indicates that a "window of opportu- 
nity" exists along the exogenous antigen processing pathway, 
within which a T  cell epitope must be made available for 
capture by class II MHC. 
Earlier studies in B cells (4) and macrophages (3) reported 
differential enhancement of T cell activation by different an- 
tibody specificities. In the macrophage study when mixtures 
of potentiating and nonpotentiating antibodies were present, 
potentiation of B-galactosidase presentation was dominant 
(3,  18). This dearly contrasts with our results which dem- 
onstrate that in some cases bound antibody can actually shut 
down presentation to some T  cells and, moreover, does so 
in a dominant fashion. The tetrameric nature of B-galactosidase 
is likely to complicate the enhancing (via uptake) versus the 
potentially suppressive  (via processing) effects of antibodies. 
The bell-shaped curves obtained in the B-galactosidase studies 
(3), when T  cell stimulation was plotted against antibody/ 
antigen ratio, might be due to enhanced uptake at low ratio 
when some subunits in the tetramer will be processed nor- 
mally. At higher ratios, uptake will be enhanced further, but 
if all subunits are complexed presentation may be inhibited. 
In mice immunized with intact influenza virus, the T and 
B cell repertoires to the hemagglutinin are often focused on 
the same regions of the antigen (20, 21). However, it is known 
that these B cells can receive help from many helper T cells, 
including those specific for other viral proteins (22). Nonethe- 
less, it is interesting to speculate that antibody effects on pro- 
cessing may in some cases enhance presentation of neighboring 
T  cell epitopes. 
In general, the drive towards high affinity antibodies which 
do not dissociate from the antigen at endosomal pH may 
have a widespread influence on the outcome of antigen pro- 
cessing by altering the nature of the substrate for processing. 
We therefore suggest that prevailing antibody specifidties may 
influence which T  cell epitopes become dominant,  and as 
different antibody specificities emerge, may change the focus 
of the T  cell response over time. 
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